424 related articles for article (PubMed ID: 16928715)
1. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
2. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.
Tsimogianni AM; Papiris SA; Kanavaki S; Stathopoulos GT; Sotiropoulou C; Manali ED; Michalopoulou P; Roussos C; Kotanidou A
Respirology; 2009 Nov; 14(8):1114-20. PubMed ID: 19761538
[TBL] [Abstract][Full Text] [Related]
3. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
[TBL] [Abstract][Full Text] [Related]
4. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
5. Relation of sputum colour to bacterial load in acute exacerbations of COPD.
Brusse-Keizer MG; Grotenhuis AJ; Kerstjens HA; Telgen MC; van der Palen J; Hendrix MG; van der Valk PD
Respir Med; 2009 Apr; 103(4):601-6. PubMed ID: 19027281
[TBL] [Abstract][Full Text] [Related]
6. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C; Hendrix R
Clin Infect Dis; 2004 Oct; 39(7):980-6. PubMed ID: 15472849
[TBL] [Abstract][Full Text] [Related]
7. [Exacerbations of chronic obstructive pulmonary disease and the role of sputum bacteriological examination].
Noweta K; Frankowska M; Grzelewska-Rzymowska I
Pneumonol Alergol Pol; 2006; 74(4):396-402. PubMed ID: 17427149
[TBL] [Abstract][Full Text] [Related]
8. A prediction model for bacterial etiology in acute exacerbations of COPD.
Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
[TBL] [Abstract][Full Text] [Related]
9. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
Soler N; Esperatti M; Ewig S; Huerta A; Agustí C; Torres A
Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352
[TBL] [Abstract][Full Text] [Related]
10. Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease.
Miravitlles M; Marín A; Monsó E; Vilà S; de la Roza C; Hervás R; Esquinas C; García M; Millares L; Morera J; Torres A
Respir Res; 2010 May; 11(1):58. PubMed ID: 20470372
[TBL] [Abstract][Full Text] [Related]
11. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
[TBL] [Abstract][Full Text] [Related]
12. [Bacterial pathogens in sputum and degree of bronchial obstruction in patients with acute exacerbation of chronic obstructive pulmonary disease].
Biagini M; Rossi M
Recenti Prog Med; 2002 Sep; 93(9):470-3. PubMed ID: 12355983
[TBL] [Abstract][Full Text] [Related]
13. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.
Roche N; Kouassi B; Rabbat A; Mounedji A; Lorut C; Huchon G
Respiration; 2007; 74(1):19-25. PubMed ID: 16675894
[TBL] [Abstract][Full Text] [Related]
14. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
Seemungal TA; Wilkinson TM; Hurst JR; Perera WR; Sapsford RJ; Wedzicha JA
Am J Respir Crit Care Med; 2008 Dec; 178(11):1139-47. PubMed ID: 18723437
[TBL] [Abstract][Full Text] [Related]
15. [The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease].
Targowski T; Jahnz-Rózyk K
Pol Merkur Lekarski; 2010 Apr; 28(166):311-4. PubMed ID: 20491344
[TBL] [Abstract][Full Text] [Related]
16. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Daniels JM; Snijders D; de Graaff CS; Vlaspolder F; Jansen HM; Boersma WG
Am J Respir Crit Care Med; 2010 Jan; 181(2):150-7. PubMed ID: 19875685
[TBL] [Abstract][Full Text] [Related]
17. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?
Sethi S
Proc Am Thorac Soc; 2004; 1(2):109-14. PubMed ID: 16113422
[TBL] [Abstract][Full Text] [Related]
18. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
Sethi S; Wrona C; Eschberger K; Lobbins P; Cai X; Murphy TF
Am J Respir Crit Care Med; 2008 Mar; 177(5):491-7. PubMed ID: 18079493
[TBL] [Abstract][Full Text] [Related]
20. Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice.
Llor C; Bjerrum L; Munck A; Hansen MP; Córdoba GC; Strandberg EL; Ovhed I; Radzeviciene R; Cots JM; Reutskiy A; Caballero L
Ther Adv Respir Dis; 2013 Jun; 7(3):131-7. PubMed ID: 23325784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
